Introduction
============

Most politicians and other decision-makers using guidelines for exposure to radiofrequency (RF) radiation seem to ignore the risks to human health and the environment. The fact that the International Agency for Research on Cancer (IARC) at the World Health Organization (WHO) in May 2011 classified RF radiation in the frequency range of 30 kHz to 300 GHz to be a 'possible' human carcinogen, Group 2B ([@b1-ol-0-0-11876],[@b2-ol-0-0-11876]), is being ignored. This has been recently exemplified in a hearing at the Tallinn Parliament in Estonia ([@b3-ol-0-0-11876]).

An important factor may be the influence on politicians by individuals and organizations with inborn conflicts of interests (COIs) and their own agenda in supporting the no-risk paradigm ([@b4-ol-0-0-11876],[@b5-ol-0-0-11876]). The International Commission on Non-Ionizing Radiation Protection (ICNIRP) has repeatedly ignored scientific evidence on adverse effects of RF radiation to humans and the environment. Their guidelines for exposure are based solely on the thermal (heating) paradigm and were first published in ICNIRP 1998 ([@b6-ol-0-0-11876]), updated in ICNIRP 2009 ([@b7-ol-0-0-11876]) and have now been newly published in ICNIRP 2020 ([@b8-ol-0-0-11876]), with no change of concept, only relying on thermal effects from RF radiation on humans. The large amount of peer-reviewed science on non-thermal effects has been ignored in all ICNIRP evaluations ([@b9-ol-0-0-11876],[@b10-ol-0-0-11876]). Additionally, ICNIRP has successfully maintained their obsolete guidelines worldwide.

COIs can be detrimental, and it is necessary to be as unbiased as possible when assessing health risks. There are three points that should be emphasized. Firstly, the evidence regarding health risks from environmental factors may not be unambiguous, and therefore informed judgements must be made. Furthermore, there are gaps in knowledge that call for experienced evaluations, and no conclusion can be reached without value judgements. Secondly, paradigms are defended against the evidence and against external assessments by social networks in the scientific community. Thirdly, the stronger the impact of decisions about health risks on economic, military and political interests, the stronger will stakeholders try to influence these decision processes.

Since the IARC evaluation in 2011 ([@b1-ol-0-0-11876],[@b2-ol-0-0-11876]), the evidence on human cancer risks from RF radiation has been strengthened based on human cancer epidemiology reports ([@b9-ol-0-0-11876]--[@b11-ol-0-0-11876]), animal carcinogenicity studies ([@b12-ol-0-0-11876]--[@b14-ol-0-0-11876]) and experimental findings on oxidative mechanisms ([@b15-ol-0-0-11876]) and genotoxicity ([@b16-ol-0-0-11876]). Therefore, the IARC Category should be upgraded from Group 2B to Group 1, a human carcinogen ([@b17-ol-0-0-11876]).

The deployment of the fifth generation, 5G, of RF radiation is a major concern in numerous countries, with groups of citizens trying to implement a moratorium until thorough research on adverse effects on human health and the environment has been performed. An appeal for a moratorium, currently signed by \>390 international scientists and medical doctors, was sent to the European Union (EU) in September 2017 ([@b18-ol-0-0-11876]), currently with no EU response ([@b19-ol-0-0-11876]). Several regions have implemented a moratorium on the deployment of 5G motivated by the lack of studies on health effects, for instance Geneva ([@b20-ol-0-0-11876]).

In the present article, the current situation in Switzerland is discussed as an example ([@b21-ol-0-0-11876]). Additionally, the ICNIRP 2020 evaluation is discussed ([@b8-ol-0-0-11876]).

Evaluation of health risks in Switzerland
=========================================

Several Swiss citizens have brought to our attention that Associate Professor Martin Röösli is the chair of two important government expert groups in Switzerland (directeur), despite possible COIs and a history of misrepresentation of science ([@b22-ol-0-0-11876],[@b23-ol-0-0-11876]). These groups are Beratende Expertengruppe NIS (BERENIS; the Swiss advisory expert group on electromagnetic fields and non-ionizing radiation) ([@b24-ol-0-0-11876]), and the subgroup 3, the Mobile Communications and Radiation Working Group of the Department of the Environment, Transport, Energy and Communications/Eidgenössisches Departement für Umwelt, Verkehr, Energie und Kommunikation, evaluating RF-radiation health risks from 5G technology ([@b25-ol-0-0-11876],[@b26-ol-0-0-11876]).

The conclusions made in the recent Swiss government 5G report are biased and can be found here ([@b27-ol-0-0-11876],[@b28-ol-0-0-11876]). This 5G report concluded that there is an absence of short-term health impacts and an absence or insufficient evidence of long-term effects \[see Table 17 (Tableau 17) on page 69 in the French version ([@b27-ol-0-0-11876]) and Table 17 (Tabelle 17) on page 67 in the German version ([@b28-ol-0-0-11876])\].

Furthermore, it was reported that there is limited evidence for glioma, neurilemmoma (schwannoma) and co-carcinogenic effects, and insufficient evidence for effects on children from prenatal exposure or from their own mobile phone use. Regarding cognitive effects, fetal development and fertility (sperm quality), the judgement was that the evidence on harmful effects is insufficient. These evaluations were strikingly similar to those of the ICNIRP (see Appendix B in ICNIRP 2020; 8). Other important endpoints, such as effects on blood-brain barrier, cell proliferation, apoptosis (programmed cell death), oxidative stress (reactive oxygen species) and gene and protein expression, were not evaluated.

According to Le Courrier November 19, 2019, Martin Röösli presented the conclusion in an interview in the following way: '*Sur l\'aspect sanitaire pur, «le groupe de travail constate que, jusqu\'à présent, aucun effet sanitaire n\'a été prouvé de manière cohérente en dessous des valeurs limites d\'immissions fixées», résume Martin Röösli, professeur d\'épidémiologie environnementale à l\'Institut tropical et de santé publique suisse*' ([@b29-ol-0-0-11876]). \[*Regarding the health issue, the working group concludes that, until now, no health effect has been consistently proven below the given exposure limits, summarizes Martin Röösli, professor in environmental epidemiology at the Swiss Tropical and Public Health Institute*\].

This Swiss evaluation is scientifically inaccurate and is in opposition to the opinion of numerous scientists in this field ([@b18-ol-0-0-11876]). In addition, 252 electromagnetic field (EMF) scientists from 43 countries, all with published peer-reviewed research on the biologic and health effects of nonionizing electromagnetic fields (RF-EMF) have stated that:

'*Numerous recent scientific publications have shown that RF-EMF affects living organisms at levels well below most international and national guidelines. Effects include increased cancer risk, cellular stress, increase in harmful free radicals, genetic damages, structural and functional changes of the reproductive system, learning and memory deficits, neurological disorders, and negative impacts on general well-being in humans. Damage goes well beyond the human race, as there is growing evidence of harmful effects to both plant and animal life*' ([@b30-ol-0-0-11876]).

We are concerned that the Swiss 5G report may be influenced by ties to mobile phone companies (COIs) by one or several members of the evaluating group.

COIs
====

Funding from telecom companies is an obvious COI. Martin Röösli has been a member of the board of the telecom funded Swiss Research Foundation for Electricity and Mobile Communication (FSM) organization and he has received funding from the same organization ([@b31-ol-0-0-11876]--[@b33-ol-0-0-11876]).

It should be noted that the FSM is a foundation that serves formally as an intermediate between industry and researchers. According to their website, among the five founders of FSM who '*provided the initial capital of the Foundation*' four are telecommunications companies: Swisscom, Salt, Sunrise, 3G Mobile (liquidated in 2011). The fifth founder is ETH Zurich (technology and engineering university). There are only two sponsors, Swisscom (telecommunications) and Swissgrid (energy), who '*support the FSM with annual donations that allow for both the management of the Foundation and research funding*' ([@b34-ol-0-0-11876]).

The same situation applies to being a member of ICNIRP ([Table I](#tI-ol-0-0-11876){ref-type="table"}) ([@b35-ol-0-0-11876]). In 2008, the Ethical Council at Karolinska Institute in Stockholm stated that being a member of ICNIRP is a potential COI. Such membership should always be declared. This verdict was based on activities by Anders Ahlbom in Sweden, at that time a member of ICNIRP, but is a general statement (2008-09-09; Dnr, 3753-2008-609). In summary: '*It is required that all parties clearly declare ties and other circumstances that may influence statements, so that decision makers and the public may be able to make solid conclusions and interpretations. AA \[Anders Ahlbom\] should thus declare his tie to ICNIRP whenever he makes statements on behalf of authorities and in other circumstances*' (translated into English).

COIs with links to industry are of great importance; these links may be direct or indirect funding for research, payment of travel expenses, participation in conferences and meetings, presentation of research, etc. Such circumstances are not always declared as exemplified above. A detailed description was recently presented for ICNIRP members ([@b22-ol-0-0-11876]).

ICNIRP
======

ICNIRP is a non-governmental organization (NGO) based in Germany. Members are selected via an internal process, and the organization lacks transparency and does not represent the opinion of the majority of the scientific community involved in research on health effects from RF radiation. Independent international EMF scientists in this research area have declared that: '*In 2009, the ICNIRP released a statement saying that it was reaffirming its 1998 guidelines, as in their opinion, the scientific literature published since that time has provided no evidence of any adverse effects below the basic restrictions and does not necessitate an immediate revision of its guidance on limiting exposure to high frequency electromagnetic fields. ICNIRP continues to the present day to make these assertions, in spite of growing scientific evidence to the contrary. It is our opinion that, because the ICNIRP guidelines do not cover long-term exposure and low-intensity effects, they are insufficient to protect public health*' ([@b30-ol-0-0-11876]).

ICNIRP only acknowledges thermal effects from RF radiation. Therefore, the large body of research on detrimental non-thermal effects is ignored. This was further discussed in a peer-reviewed scientific comment article ([@b3-ol-0-0-11876]).

In 2018, ICNIRP published '*ICNIRP Note: Critical Evaluation of Two Radiofrequency Electromagnetic Field Animal Carcinogenicity Studies Published in 2018*' ([@b36-ol-0-0-11876]). It is surprising that this note claims that the histopathological evaluation in the US National Toxicology Program (NTP) study on animals exposed to RF radiation was not blinded ([@b12-ol-0-0-11876],[@b13-ol-0-0-11876]). In fact, unfounded critique of the NTP study had already been rebutted ([@b37-ol-0-0-11876]); however, this seems to have had little or no impact on this ICNIRP note casting doubt on the findings of the animal study: '*This commentary addresses several unfounded criticisms about the design and results of the NTP study that have been promoted to minimize the utility of the experimental data on RFR \[radiofrequency radiation\] for assessing human health risks. In contrast to those criticisms, an expert peer-review panel recently concluded that the NTP studies were well designed, and that the results demonstrated that both GSM- and CDMA-modulated RFR were carcinogenic to the heart (schwannomas) and brain (gliomas) of male rats*' ([@b37-ol-0-0-11876]).

In contrast to the opinion of the 13 ICNIRP commission members, the IARC advisory group of 29 scientists from 18 countries has recently stated that the cancer bioassay in experimental animals and mechanistic evidence warrants high priority re-evaluation of the RF radiation-induced carcinogenesis ([@b38-ol-0-0-11876]).

### ICNIRP draft

On July 11, 2018, ICNIRP released a draft on guidelines ([@b39-ol-0-0-11876]) for limiting exposure to time-varying electric, magnetic and electromagnetic fields (100 kHz to 300 GHz). It was open for public consultations until October 9, 2018. Appendix B was based on assessment of health risks based on a literature survey ([@b39-ol-0-0-11876]).

Surprisingly, the IARC classification of RF-EMF exposure as Group 2B ('possibly' carcinogenic to humans) from 2011 was concealed in the background material to the new ICNIRP draft on guidelines. Notably, one of the ICNIRP commission members, Martin Röösli ([@b40-ol-0-0-11876]), was also one of the IARC experts evaluating the scientific RF carcinogenicity in May 2011 ([@b41-ol-0-0-11876]). He should be well aware of the IARC classification. The IARC classification contradicts the scientific basis for the ICNIRP guidelines, making novel guidelines necessary and providing a basis to halt the rollout of 5G technology.

Therefore, the ICNIRP provides scientifically inaccurate reviews for various governments. One issue is that only thermal (heating) effects from RF radiation are considered, and all non-thermal effects are dismissed. An analysis from the UK demonstrates these inaccuracies ([@b4-ol-0-0-11876]), also discussed in another article ([@b5-ol-0-0-11876]). All members of the ICNIRP commission are responsible for these biased statements that are not based on solid scientific evidence.

### ICNIRP release of novel guidelines for RF radiation

On March 11, 2020, ICNIRP published their novel guidelines for exposure to EMFs in the range of 100 kHz to 300 GHz, thus including 5G ([@b8-ol-0-0-11876]). The experimental studies demonstrating a variety of non-thermal biological/health effects ([@b9-ol-0-0-11876],[@b10-ol-0-0-11876]) are not considered, as in their previous guidelines ([@b6-ol-0-0-11876],[@b7-ol-0-0-11876]). Additionally, the ICNIRP increased the reference levels for the general public averaged over 6 min for RF frequencies \>2--6 GHz (those that will be used for 5G in this frequency range), from 10 W/m^2^ (Tables 5 and 7 in ref. no. 6) to 40 W/m^2^ (Table 6 in ref. no. 8), which paves the way for even higher exposure levels to 5G than the already extremely high ones.

Background dosimetry is discussed in Appendix A of the ICNIRP 2020 guidelines ([@b8-ol-0-0-11876]). The discussion on 'Relevant Biophysical Mechanisms' should be criticized. The only mechanism considered by ICNIRP is temperature rise, which may also occur with 5G exposure, apart from the established non-thermal biological/health effects ([@b42-ol-0-0-11876],[@b43-ol-0-0-11876]). It is well known among experts in the EMF-bioeffects field that the recorded cellular effects, such as DNA damage, protein damage, chromosome damage and reproductive declines, and the vast majority of biological/health effects are not accompanied by any significant temperature rise in tissues ([@b44-ol-0-0-11876]--[@b47-ol-0-0-11876]). The ion forced-oscillation mechanism ([@b48-ol-0-0-11876]) should be referred to as a plausible non-thermal mechanism of irregular gating of electrosensitive ion channels on cell membranes, resulting in disruption of the cell electrochemical balance and initiating free radical release and oxidative stress in the cells, which in turn causes genetic damage ([@b15-ol-0-0-11876],[@b49-ol-0-0-11876]). The irregular gating of ion channels on cell membranes is associated with changes in permeability of the cell membranes, which ICNIRP admits in its summary ([@b8-ol-0-0-11876]).

Health risks are discussed in Appendix B of the ICNIRP 2020 guidelines ([@b8-ol-0-0-11876]). Again, only thermal effects are considered, whereas literature on non-thermal health consequences is disregarded ([@b9-ol-0-0-11876],[@b10-ol-0-0-11876],[@b50-ol-0-0-11876]). In spite of public consultations on the draft, the final published version on health effects is virtually identical to the draft version, and comments seem to have been neglected ([@b19-ol-0-0-11876]). In the following section, Appendix B on health effects ([@b8-ol-0-0-11876]) is discussed.

Appendix B starts with: '*The World Health Organization (WHO) has undertaken an in-depth review of the literature on radiofrequency electromagnetic fields (EMFs) and health, which was released as a Public Consultation Environmental Health Criteria Document in 2014... Further, the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), a European Commission initiative, also produced a report on potential health effects of exposure to electromagnetic fields (SCENIHR 2015), and the Swedish Radiation Safety Authority (SSM) have produced several international reports regarding this issue (SSM 2015, 2016, 2018). Accordingly, the present guidelines have used these literature reviews as the basis for the health risk assessment associated with exposure to radiofrequency EMFs rather than providing another review of the individual studies'*.

In the last 11 years since its previous ICNIRP 2009 statement ([@b7-ol-0-0-11876]), ICNIRP has not managed to conduct a novel evaluation of health effects from RF radiation. However, as shown in [Table I](#tI-ol-0-0-11876){ref-type="table"}, several of the present ICNIRP members are also members of other committees, such as the EU Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), the Swedish Radiation Safety Authority (SSM) and the WHO, thus creating a cartel of individuals known to propagate the ICNIRP paradigm on RF radiation ([@b4-ol-0-0-11876],[@b5-ol-0-0-11876],[@b22-ol-0-0-11876],[@b51-ol-0-0-11876]). In fact, six of the seven expert members of the WHO, including Emelie van Deventer, were also included in ICNIRP ([@b5-ol-0-0-11876],[@b7-ol-0-0-11876]). Therefore, Emilie van Deventer, the team leader of the Radiation Programme at WHO (the International EMF Project), is an observer on the main ICNIRP commission, and SSM seems to be influenced by ICNIRP. Among the current seven external experts (Danker-Hopfe, Dasenbrock, Huss, Harbo Polusen, van Rongen, Röösli and Scarfi), five are also members of ICNIRP, and van Deventer used to be part of SSM.

As discussed elsewhere ([@b5-ol-0-0-11876]), it is unlikely that a person\'s evaluation of health risks associated with exposure to RF radiation would differ depending on what group the person belongs to. Therefore, by selecting group members, the final outcome of the evaluation may already be predicted (no-risk paradigm). Additionally, we believe that this may compromise sound scientific code of conduct.

The SCENIHR report from 2015 ([@b52-ol-0-0-11876]) has been used to legitimate the further expansion of the wireless technology and has been the basis for its deployment in a number of countries. One method, applied in the SCENIHR report, to dismiss cancer risks involves the selective inclusion of studies, excluding studies reporting cancer risks and including some investigations with inferior epidemiological quality. The report has been heavily criticized by researchers with no COI ([@b53-ol-0-0-11876]): '*In January of 2015, the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) published its final opinion on (P)otential health effects of exposure to electromagnetic fields... SCENIHR has not answered the question it was appointed to investigate. The Committee has answered a different question, limiting its conclusions to whether certainty or causal effect is established, instead of possibility of health risks... Overall, SCENIHR has not conducted a scientific review process for judging possible health risks. This results in erroneous and deceptive conclusions by failing to conclude such possible health risks do exist. Evidence that SCENIHR has presented clearly and conclusively demonstrates that EMF health risks are possible, and in some cases are established. The Committee is obligated to draw to the attention of the European Commission that EMF is a new and emerging problem that may pose an actual or potential threat*'.

Regarding the SSM, only yearly updates are available and no overall evaluations are made. Therefore, no thorough review is presented. Over the years, the ICNIRP has dominated this committee ([Table I](#tI-ol-0-0-11876){ref-type="table"}). Therefore, it is unlikely that the opinion of the SSM will differ from that of the ICNIRP.

In 2014, the WHO launched a draft of a Monograph on RF fields and health for public comments ([@b54-ol-0-0-11876]). It should be noted that the WHO issued the following statement: '*This is a draft document for public consultation. Please do not quote or cite*'. ICNIRP completely ignored that request and used the aforementioned document. The public consultations on the draft document were dismissed and never published.

In addition to van Deventer, five of the six members (Mann, Feychting, Oftedal, van Rongen, and Scarfi) of the Core Group in charge of the WHO draft were also affiliated with ICNIRP, which constitutes a COI ([Table I](#tI-ol-0-0-11876){ref-type="table"}). Scarfi is a former member of ICNIRP ([@b5-ol-0-0-11876]). Several individuals and groups sent critical comments to the WHO on the numerous shortcomings in the draft of the Monograph on RF radiation. In general, the WHO never responded to these comments and it is unclear to what extent, if any, they were even considered. Nevertheless, the final version of the WHO 'in-depth review' has never been published. Instead, WHO made a call on October 8, 2019 (Emelie van Deventer), for systematic reviews to analyze and synthesize the available evidence: '*Through this Call, WHO invites eligible teams to indicate their interest in undertaking a systematic review on one (or more) of the following topics: SR1 - Effect of exposure to RF on cancer (human observational studies); SR2 - Effect of exposure to RF on cancer (animal studies); SR3 - Effect of exposure to RF on adverse reproductive outcomes (human observational studies); SR4 - Effect of exposure to RF on adverse reproductive outcomes (animal and in vitro studies); SR5 - Effect of exposure to RF on cognitive impairment (human observational studies; SR6 - Effect of exposure to RF on cognitive impairment (human experimental studies); SR7 - Effect of exposure to RF on symptoms (human observational studies); SR8 - Effect of exposure to RF on symptoms (human experimental studies; SR9 - Effect of exposure to RF on biomarkers of oxidative stress; SR10 - Effect of exposure to heat from any source and pain, burns, cataract and heat-related illness*'.

The authors of the present article were part of a team that applied to review SR1- human cancer. On December 20, 2019, the following reply was received from the WHO Radiation Programme: '*After careful review, we have decided to choose another team for this systematic review*'.

Transparency is of importance for the whole process. Therefore, a query was sent to the WHO requesting information regarding the following points: '*Who did the evaluation of the groups that answered the call? What criteria were applied? How many groups had submitted and who were these? Which groups were finally chosen for the different packages?*'. In spite of sending the request four times, January 2, January 3, April 7 and April 30, 2020, there has been no reply from WHO. This appears to be a secret process behind closed doors. These circumstances have also been reported in Microwave News ([@b55-ol-0-0-11876]).

It is important to comment on the current ICNIRP evaluation. Notably, on February 27, 2020, two weeks before the ICNIRP publication, the WHO Team on Public Health, Environmental and Social Determinants of Health issued a statement on 5G mobile networks and health: '*To date, and after much research performed, no adverse health effect has been causally linked with exposure to wireless technologies'* ([@b56-ol-0-0-11876]). This statement is not correct based on current knowledge ([@b4-ol-0-0-11876],[@b5-ol-0-0-11876],[@b9-ol-0-0-11876]--[@b11-ol-0-0-11876],[@b17-ol-0-0-11876],[@b19-ol-0-0-11876]) and was without a personal signature. The lack of research on 5G safety has been previously discussed ([@b19-ol-0-0-11876]). Furthermore, there is no evidence that can 'causally link' an adverse effect to an exposure. Causality is no empirical fact, it is an interpretation.

In the following section, only one (cancer) of the eight different end points in the ICNIRP publication ([@b8-ol-0-0-11876]) is discussed, since it deals with our main research area.

viii\) Cancer.

'I*n summary, no effects of radiofrequency EMFs on the induction or development of cancer have been substantiated*.

Summary
=======

*The only substantiated adverse health effects caused by exposure to radiofrequency EMFs are nerve stimulation, changes in the permeability of cell membranes, and effects due to temperature elevation. There is no evidence of adverse health effects at exposure levels below the restriction levels in the ICNIRP (1998) guidelines and no evidence of an interaction mechanism that would predict that adverse health effects could occur due to radiofrequency EMF exposure below those restriction levels'*.

Comments
========

The ICNIRP draft ([@b39-ol-0-0-11876]) has been previously described to some extent ([@b19-ol-0-0-11876]). The published final version on health effects is virtually similar to the draft. It cannot be taken at face value as scientific evidence of no risk from RF radiation. One example is the following statement (p. 41): '*...a set of case-control studies from the Hardell group in Sweden report significantly increased risks of both acoustic neuroma and malignant brain tumors already after less than five years since the start of mobile phone use, and at quite low levels of cumulative call time'*.

This allegation is not correct according to our publication for glioma ([@b11-ol-0-0-11876]). In the shortest latency group \>1--5 years, the risk of glioma was not increased (odds ratio (OR), 1.1; 95% CI, 0.9-1.4) for use of wireless phones (mobile phone and/or cordless phone). There was a statistically significant increased risk of glioma per 100 h of cumulative use (OR, 1.011; 95% CI, 1.008-1.014) and per year of latency (OR, 1.032; 95% CI, 1.019-1.046) ([@b11-ol-0-0-11876]). These published results are in contrast to the ICNIRP claims.

Regarding acoustic neuroma, the corresponding detailed results are reported in our previous study ([@b57-ol-0-0-11876]). The shortest latency period \>1--5 years yielded an OR of 1.2 (95% CI, 0.8-1.6) for use of wireless phones; the risk increased per 100 h of cumulative use (OR, 1.008; 95% CI, 1.002-1.014) and per year of latency (OR, 1.056; 95% CI, 1.029-1.085) ([@b57-ol-0-0-11876]). Therefore, the allegation by ICNIRP is false.

It is remarkable that ICNIRP is uninformed and that their writing is based on a misunderstanding of the peer-reviewed published articles as exemplified above. Additionally, our studies ([@b11-ol-0-0-11876],[@b57-ol-0-0-11876]) and another study by Coureau *et al* ([@b58-ol-0-0-11876]), as well as the IARC evaluation from 2011 ([@b1-ol-0-0-11876],[@b2-ol-0-0-11876]), are not included among the references. Several statements by ICNIRP are made without any scientific references. On the other hand, the Danish cohort study on mobile phone use ([@b59-ol-0-0-11876]) is included, in spite of the fact that it was judged by IARC ([@b1-ol-0-0-11876],[@b2-ol-0-0-11876]), as well as in our review ([@b60-ol-0-0-11876]), to be uninformative. A biased article written by authors including ICNIRP members, used to 'prove' the no-risk paradigm for RF radiation carcinogenesis ([@b23-ol-0-0-11876]), is cited by ICNIRP. Notably, the article has not undergone relevant peer-review and we believe that it should not have been published in its current version. The shortcomings in the aforementioned article are discussed in the following sections. As discussed below, another claim ([@b23-ol-0-0-11876]) is incorrect regarding increased risk of brain tumors associated with use of wireless phones: '*However, they are not consistent with trends in brain cancer incidence rates from a large number of countries or regions, which have not found any increase in the incidence since mobile phones were introduced'*.

The criticism of the ICNIRP draft guidelines from 2018 by the EMF call ([@b61-ol-0-0-11876]) can also be applied to the current ICNIRP publication. The call has been signed by 164 scientists and medical doctors, as well as 95 NGOs: '*The International Commission on Non-Ionizing Radiation Protection (ICNIRP) issued draft Guidelines on 11th July 2018 for limiting exposure to electric, magnetic and electromagnetic fields (100 kHz to 300 GHz).1 These guidelines are unscientific, obsolete and do not represent an objective evaluation of the available science on effects from this form of radiation. They ignore the vast amount of scientific findings that clearly and convincingly show harmful effects at intensities well below ICNIRP guidelines.2 The guidelines are inadequate to protect humans and the environment. ICNIRP guidelines only protect against acute thermal effects from very short and intense exposure. The guidelines do not protect against harmful effects from low-intensity and long-term exposure, such as cancer, reproductive harm, or effects on the nervous system, although these effects are convincingly shown to appear from chronic exposure at intensities below ICNIRP limits.2,3*

*ICNIRP\'s mandate to issue exposure guidelines needs to be seriously questioned. ICNIRP is not independent of industry ties as it claims.12,13 Its opinions are not objective, not representative of the body of scientific evidence, but are biased in favor of industry. It is obvious from their reluctance to consider scientific findings of harm that ICNIRP protects industry, not the public health, nor the environment*.

*We ask the United Nations, the World Health Organization, and all governments to support the development and consideration of medical guidelines16, that are independent of conflict of interests in terms of direct or indirect ties to industry, that represent the state of medical science, and that are truly protective'*.

In the recent report on ICNIRP published by two Members of the European Parliament it is concluded: '*That is the most important conclusion of this report: For really independent scientific advice we cannot rely on ICNIRP. The European Commission and national governments, from countries like Germany, should stop funding ICNIRP. It is high time that the European Commission creates a new, public and fully independent advisory council on non-ionizing radiation'* ([@b22-ol-0-0-11876]).

Other examples of scientific misrepresentation
==============================================

### Published article

This section discusses an article with conclusions not substantiated by scientific evidence, representing a biased evaluation of cancer risks from mobile phone use and is an example of lack of objectivity and impartiality ([@b23-ol-0-0-11876]). The aforementioned report was used by ICNIRP 2020 ([@b8-ol-0-0-11876]) to validate that no risks have been found for brain and head tumors. Therefore, the article should be discussed in further detail.

The aforementioned article has numerous severe scientific deficiencies. One is that the results on use of cordless phones as a risk factor for brain tumors are not discussed. In fact, detailed results on cordless phones in studies by Hardell *et al* ([@b11-ol-0-0-11876],[@b57-ol-0-0-11876]) are omitted.

When discussing glioma risk, all results on cumulative use of mobile phones, as well as ipsilateral or contralateral use associated with tumor localization in the brain, are omitted from the figures in the main text. Some results in the article by Röösli *et al* ([@b23-ol-0-0-11876]), such as cumulative use, can be found in the Supplementary Material, although the increased risk among heavy users is disregarded ([@b11-ol-0-0-11876],[@b57-ol-0-0-11876],[@b58-ol-0-0-11876],[@b62-ol-0-0-11876]). In Supplementary Figure 4, all odds ratios regarding long-term (≥10 years) use of mobile phones are above unity (\>1.0) for glioma and neuroma ([@b23-ol-0-0-11876]). No results are provided for ipsilateral mobile phone use (same side of tumor localization and mobile phone use), which is of large biological importance. Results on cumulative use, latency and ipsilateral use are especially important for risk assessment and have shown a consistent pattern of increased risk for brain and head tumors ([@b11-ol-0-0-11876],[@b57-ol-0-0-11876]).

In the aforementioned article, recall bias is discussed as the reason for increased risk ([@b23-ol-0-0-11876]). The studies by Hardell *et al* ([@b11-ol-0-0-11876],[@b57-ol-0-0-11876]) included all types of brain tumors. In one analysis, meningioma cases in the same study were used as the 'control' entity ([@b11-ol-0-0-11876]), and still a statistically significant increased risk of glioma was identified for mobile phone use (ipsilateral OR, 1.4; 95% CI, 1.1-1.8; contralateral OR, 1.0; 95% CI, 0.7-1.4) and for cordless phone use (ipsilateral OR, 1.4; 95% CI, 1.1-1.9; contralateral OR, 1.1; 95% CI, 0.8-1.6). If the results were 'explained' by recall bias, similar results would have been obtained for both glioma and meningioma. Thus, this type of analyses would not have yielded an increased glioma risk. Also, for acoustic neuroma a statistically significant increased risk was found using meningioma cases as 'controls' ([@b57-ol-0-0-11876]). Therefore, the results in the studies by Hardell *et al* ([@b11-ol-0-0-11876],[@b57-ol-0-0-11876]) cannot be explained by a systematic difference in assessment of exposure between cases and controls. These important methodological findings were disregarded by Röösli *et al* ([@b23-ol-0-0-11876]).

In the analyses of long-term use of mobile phones, a Danish cohort study on mobile phone use is included ([@b59-ol-0-0-11876]), which was concluded to be uninformative in the 2011 IARC evaluation ([@b1-ol-0-0-11876],[@b2-ol-0-0-11876]). A methodological shortcoming of the aforementioned study was that only private mobile phone subscribers in Denmark between 1982 and 1995 were included in the exposure group ([@b59-ol-0-0-11876]). The most exposed group, comprising 200,507 corporate users of mobile phones, were excluded and instead included in the unexposed control group consisting of the rest of the Danish population. Users with mobile phone subscription after 1995 were not included in the exposed group and were thus treated as unexposed at the time of cut-off of the follow up. No analysis of laterality of mobile phone use in relation to tumor localization was performed. Notably, this cohort study is now included in the risk calculations, although Martin Röösli was a member of the IARC evaluation group and should have been aware of the IARC decision. The numerous shortcomings in the Danish cohort study, discussed in detail in a peer-reviewed article ([@b60-ol-0-0-11876]), are omitted in the article by Röösli *et al* ([@b23-ol-0-0-11876]).

Regarding animal studies, a study by Falcioni *et al* ([@b14-ol-0-0-11876]) at the Ramazzini Institute on RF radiation carcinogenesis is only mentioned as a reference, but the results are not discussed. In fact, these findings ([@b14-ol-0-0-11876]) provide supportive evidence on the risk found in human epidemiology studies ([@b3-ol-0-0-11876]), as well as the results in the NTP study ([@b12-ol-0-0-11876],[@b13-ol-0-0-11876]).

Furthermore, for incidence studies on brain tumors, the results are not presented in an adequate way. There is a lot of emphasis on the Swedish Cancer Register data ([@b63-ol-0-0-11876],[@b64-ol-0-0-11876]), but the numerous shortcomings in the reporting of brain tumor cases to the register are not discussed. These shortcomings have been presented in detail in a previous study ([@b63-ol-0-0-11876]), but are disregarded by Röösli *et al* ([@b23-ol-0-0-11876]).

There is clear evidence from several countries regarding increasing numbers of patients with brain tumors, such as in Sweden ([@b63-ol-0-0-11876],[@b64-ol-0-0-11876]), England ([@b65-ol-0-0-11876]), Denmark ([@b66-ol-0-0-11876]) and France ([@b67-ol-0-0-11876]).

The article by Röösli *et al* ([@b23-ol-0-0-11876]), does not represent an objective scientific evaluation of brain and head tumor risk associated with the use of wireless phones, and should thus be disregarded. By omitting results of biological relevance and including studies that have been judged to be uninformative, the authors come to the conclusion that there are no risks: '*In summary, current evidence from all available studies including in vitro, in vivo, and epidemiological studies does not indicate an association between MP \[mobile phone\] use and tumors developing from the most exposed organs and tissues'*.

Röösli *et al* ([@b23-ol-0-0-11876]), disregard the concordance of increased cancer risk in human epidemiology studies ([@b11-ol-0-0-11876],[@b57-ol-0-0-11876],[@b58-ol-0-0-11876],[@b62-ol-0-0-11876]) animal studies ([@b12-ol-0-0-11876]--[@b14-ol-0-0-11876],[@b68-ol-0-0-11876],[@b69-ol-0-0-11876]) and laboratory studies ([@b15-ol-0-0-11876],[@b16-ol-0-0-11876],[@b37-ol-0-0-11876]). It is unfortunate that the review process of the aforementioned article has not been of adequate quality. Finally, there is no statement in the article of specific funding of this particular work, which is not acceptable. Only a limited number of comments on general funding are provided. It is not plausible that there was no funding for the study. We believe that, due to its numerous limitations, the aforementioned article should not have been published.

### CEFALO

In 2011, a case-control study on mobile phone use and brain tumor risk among children and adolescents termed CEFALO was published ([@b70-ol-0-0-11876]). The study appears to have been designed to misrepresent the true risk, since the following question regarding cordless phone use was asked: '*How often did \[child\] speak on the cordless phone in the first 3 years he/she used it regularly?*'.

There are no scientific valid reasons to limit the investigation to the first 3 years. The result is a misrepresentation and a wrong exposure classification, since Aydin *et al* ([@b70-ol-0-0-11876]) willingly omitted any increase in the child\'s use of and exposure from cordless phone radiation after the first 3 years of use. This unscientific treatment of cordless phone exposure was not mentioned in the article other than in a footnote of a table and in the methods section ([@b70-ol-0-0-11876]); however, no explanation was provided: '*Specifically, we analyzed whether subjects ever used baby monitors near the head, ever used cordless phones, and the cumulative duration and number of calls with cordless phones in the first 3 years of use'*.

Since previous studies have demonstrated that these phone types, in addition to mobile phones, increase brain tumor risk ([@b11-ol-0-0-11876],[@b57-ol-0-0-11876]), we believe that the exclusion of a complete exposure history on the use of cordless phones represents scientific misconduct.

In a critical comment the authors of the present study wrote: '*Further support of a true association was found in the results based on operator-recorded use for 62 cases and 101 controls, which for time since first subscription \>2.8 years yielded OR 2.15 (95% CI 1.07-4.29) with a statistically significant trend (P = 0.001). The results based on such records would be judged to be more objective than face-to-face interviews, as in the study that clearly disclosed to the interviewer who was a case or a control. The authors disregarded these results on the grounds that there was no significant trend for operator data for the other variables - cumulative duration of subscriptions, cumulative duration of calls and cumulative number of calls. However, the statistical power in all the latter groups was lower since data was missing for about half of the cases and controls with operator-recorded use, which could very well explain the difference in the results*' ([@b71-ol-0-0-11876]).

Our conclusion was that: '*We consider that the data contain several indications of increased risk, despite low exposure, short latency period, and limitations in the study design, analyses and interpretation. The information certainly cannot be used as reassuring evidence against an association, for reasons that we discuss in this commentary*' ([@b71-ol-0-0-11876]).

This is in contrast to the authors that claimed that the study was reassuring of no risk in a press release from Martin Röösli, July 28, 2011: '*Kein erhöhtes Hirntumorrisiko bei Kindern und Jugendlichen wegen Handys... Die Resultate sind beruhigend*' \['*No increased brain tumour risk in children and adolescents for mobile phone users... The results are reassuring*'\] ([@b72-ol-0-0-11876]).

A similar press release was issued by Maria Feychting at the Karolinska Institute in Stockholm stating: '*Reassuring results from first study on young mobile users and cancer risk... The so called CEFALO study does not show an increased brain tumor risk for young mobile users'* ([@b73-ol-0-0-11876]). Considering the results and the numerous scientific shortcomings in the study ([@b70-ol-0-0-11876]), the statements in these press releases are not correct.

Discussion
==========

There is no doubt that several individuals included in [Table I](#tI-ol-0-0-11876){ref-type="table"} are influential, being members, as well as having consulting assignments, in several organizations, such as ICNIRP, BERENIS, the SSM, the Program Electromagnetic Fields and Health from ZonMw in the Netherlands, and the Rapid Response Group for the Japan EMF Information Center ([@b74-ol-0-0-11876]).

In fact, there appears to be a cartel of individuals working on this issue ([@b75-ol-0-0-11876]). Associate Professor Martin Röösli has had the chance to provide his view on the content of the present article relating to him. The only message from him was in an e-mail dated January 16, 2020: '*Just to be clear, all my research is funded by public money or not-for -profit fundations \[foundations\]. I think you will not help an important debate if you spread fake news'*. Obviously, as described in the present article, his comment is not correct considering his funding from the telecom industry ([@b76-ol-0-0-11876],[@b77-ol-0-0-11876]).

As shown in [Table I](#tI-ol-0-0-11876){ref-type="table"}, few individuals, and mostly the same ones, are involved in different evaluations of health risks from RF radiation and will thus propagate the same views on the risks in agencies of different countries associated with the ICNIRP views ([@b4-ol-0-0-11876],[@b5-ol-0-0-11876]). Therefore, it is unlikely that they will change their opinions when participating in different organizations. Furthermore, their competence in natural sciences, such as medicine, is often low or non-existent due to a lack of education in these disciplines ([@b2-ol-0-0-11876]). Therefore, any chance for solid evaluations of medical issues is hampered. Additionally, it must be concluded that if the 'thermal only' dogma is dismissed, this will have wide consequences for the whole wireless community, including permissions for base stations, regulations of the wireless technology and marketing, plans to roll out 5G, and it would therefore have a large impact on the industry. This may explain the resistance to acknowledge the risk by ICNIRP, EU, WHO, SSM and other agencies. However, the most important aspects to consider are human wellbeing and a healthy environment. Telecoms can make profit in a variety of ways, and wireless is just one of them. They have the capacity to maintain profits by using different techniques, such as optical fiber, that will provide more data with less RF radiation exposure. Particularly when considering the liability, they are incurring in their misguided insistence of wireless expansion that may ultimately catch up to them in the form of lawsuits, such as those previously experienced by asbestos and tobacco companies ([@b78-ol-0-0-11876],[@b79-ol-0-0-11876]).

A recent book describes how deception is used to capture agencies and hijack science ([@b80-ol-0-0-11876]). There are certain tools that can be used for this. One is to re-analyze existing data using methods that are biased towards predetermined results ([@b23-ol-0-0-11876]). For example, this can be performed by hiring 'independent experts' to question scientific results and create doubt ([@b81-ol-0-0-11876],[@b82-ol-0-0-11876]). As clearly discussed in a number of chapters of the books ([@b80-ol-0-0-11876]--[@b82-ol-0-0-11876]), front groups may be created to gain access to politicians and to influence the public with biased opinions. Other methods may involve intimidating and harassing independent scientists that report health risks based on sound science, or removing all funding from scientists who do not adhere to the no-risk pro-industry paradigm. Another tool would be economic support and courting decision makers with special information sessions that mislead them on science and mask bribery ([@b3-ol-0-0-11876],[@b5-ol-0-0-11876],[@b19-ol-0-0-11876],[@b80-ol-0-0-11876]--[@b82-ol-0-0-11876]). An industry with precise marketing goals has a big advantage over a loose scientific community with little funding. Furthermore, access to regulatory agencies and overwhelming them with comments on proposed regulations is crucial ([@b3-ol-0-0-11876]). To counteract all these actions is time consuming and not always successful ([@b19-ol-0-0-11876]). Nevertheless, it is important that these circumstances are explored and published in the peer-reviewed literature as historical notes for future use.

Based on the Swiss and ICNIRP experiences, some recommendations can be made. One is to include only unbiased and experienced experts without COIs for evaluation of health risks from RF radiation. All countries should declare a moratorium on 5G until independent research, performed by scientists without any ties to the industry, confirms its safety or not. 2G, 3G, 4G and WiFi are also considered not to be safe, but 5G will be worse regarding harmful biological effects ([@b42-ol-0-0-11876],[@b83-ol-0-0-11876],[@b84-ol-0-0-11876]). The authors of the present article recommend an educational campaign to educate the public about the health risks of RF radiation exposure, and safe use of the technology, such as the deployment of wired internet in schools ([@b85-ol-0-0-11876]), as previously recommended by the European Council resolution 1815 in 2011 ([@b86-ol-0-0-11876]) and The EMF Scientist Appeal ([@b87-ol-0-0-11876]). Additionally, it is recommended that the government takes steps to markedly decrease the current exposure of the public to RF radiation, ([@b88-ol-0-0-11876],[@b89-ol-0-0-11876]). Notably, DNA damage has been identified in peripheral blood lymphocytes using the comet assay technique, and in buccal cells using the micronucleus assay, in individuals exposed to RF radiation from base stations ([@b90-ol-0-0-11876]).

Finally, an alternative approach to the flawed ICNIRP safety standards may be the comprehensive work of the European Academy for Environmental Medicine (EUROPAEM) EMF working group that has resulted in safety recommendations, which are free from the ICNIRP shortcomings ([@b50-ol-0-0-11876]). Recently, the International Guidelines on Non-Ionising Radiation (IGNIR) have accepted EUROPAEM safety recommendations ([@b91-ol-0-0-11876]). The Bioinitiative group has recommended similar safety standards based on non-thermal EMF effects ([@b92-ol-0-0-11876]). WHO and all nations should adopt the EUROPAEM/Bioinitiative/IGNIR safety recommendations, supported by the majority of the scientific community, instead of the obsolete ICNIRP standards.

In conclusion, it is important that all experts evaluating scientific evidence and assessing health risks from RF radiation do not have COIs or bias. Being a member of ICNIRP and being funded by the industry directly, or through an industry-funded foundation, constitute clear COIs. Furthermore, it is recommended that the interpretation of results from studies on health effects of RF radiation should take sponsorship from the telecom or other industry into account. It is concluded that the ICNIRP has failed to conduct a comprehensive evaluation of health risks associated with RF radiation. The latest ICNIRP publication cannot be used for guidelines on this exposure.
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Members of the WHO core group and additional experts of the Environmental Health Criteria Document 2014 ([@b54-ol-0-0-11876]), EU SCENIHR 2015 ([@b52-ol-0-0-11876]), the SSM 2015--2020 ([@b93-ol-0-0-11876]) and ICNIRP commission or the Scientific Expert Group 1992--2020 ([@b94-ol-0-0-11876]).

  Members                WHO, 2014   SCENIHR, 2015   SSM, 2015--2020                                     ICNIRP, 1992--2020
  ---------------------- ----------- --------------- --------------------------------------------------- -------------------------------------------------
  Emilie van Deventer    X                           X                                                   X^[a](#tfn1-ol-0-0-11876){ref-type="table-fn"}^
  Simon Mann             X                                                                               X
  Maria Feychting        X                           (X)^[b](#tfn2-ol-0-0-11876){ref-type="table-fn"}^   X
  Gunnhild Oftedal       X                                                                               X
  Eric van Rongen        X                           X                                                   X
  Maria Rosaria Scarfi   X           X               X                                                   X
  Jukkka Juutilainen     X                                                                               X
  Denis Zmirou           X                                                                               
  Theodoros Samaras                  X                                                                   
  Norbert Leitgeb                    X                                                                   
  Anssi Auvinen                      X                                                                   X
  Heidi Danker Hopfe                 X               X                                                   
  Kjell Hansson Mild                 X                                                                   
  Mats Olof Mattsson                 X                                                                   X
  Hannu Norppa                       X                                                                   
  James Rubin            X           X                                                                   
  Joachim Schüz                      X                                                                   
  Zenon Sienkiewicz      X           X                                                                   X
  Olga Zeni              X           X                                                                   
  Anke Huss                                          X                                                   X^[c](#tfn3-ol-0-0-11876){ref-type="table-fn"}^
  Clemens Dasenbrock                                 X                                                   X
  Lars Klaeboe                                       X                                                   
  Martin Röösli          X                           X                                                   X
  Aslak Harbo Poulsen                                X                                                   

WHO Observer in the main commission ([@b95-ol-0-0-11876])

2002-2011

2020-2024. The table is based on members of WHO, SCENIHR and SSM during the defined time period(s). No other individuals among those within WHO or SCENIHR were found in the list of SSM participants. A total of 15 additional experts in WHO were not members of SCENIHR, SSM or ICNIRP. SCENIHR, Scientific Committee on Emerging and Newly Identified Health Risks; SSM, Swedish Radiation Safety Authority; WHO, World Health Organization; EU, European Union; ICNIRP, International Commission on Non-Ionizing Radiation Protection.
